Crossmark

Colchicine as a Potential Treatment Choice for COVID-19 Patients in Developing Countries: COVID-19 and Colchicine

Crossref DOI link: https://doi.org/10.4078/jrd.2022.29.1.56

Published Print: 2022-01-01

Update policy: https://doi.org/10.4078/crossmark_policy

Authors

Ghang, Byeongzu

Kim, Jinseok https://orcid.org/0000-0001-7518-3284
More Information

Full text available at:

J Rheum Dis: http://www.jrd.or.kr/journal/view.html?doi=10.4078/jrd.2022.29.1.56

Publication History

Received: 2021-08-19

Revised: 2021-10-18

Accepted: 2021-10-19

Published: 2022-01-01

ORCID

Jinseok Kim: https://orcid.org/0000-0001-7518-3284

Copyright and Licensing

Copyright: © 2022 The Korean College of Rheumatology

License: This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.